StonvexLoading…
StonvexStonvexStonvexCore line items from EMN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $8.75B | $9.38B | $9.21B | $10.58B |
Operating Income | $568.00M | $1.08B | $1.09B | $977.00M |
Net Income | $474.00M | $905.00M | $894.00M | $793.00M |
EPS (Diluted) | $4.10 | $7.67 | $7.49 | $6.35 |
Total Assets | $14.86B | $15.21B | $14.63B | $14.67B |
Total Liabilities | $8.82B | $9.36B | $9.10B | $9.43B |
Cash & Equivalents | $566.00M | $837.00M | $548.00M | $493.00M |
Free Cash Flow OCF − CapEx | $424.00M | $688.00M | $546.00M | $364.00M |
Shares Outstanding | 223.94M | 223.59M | 222.76M | 222.35M |